Document:

EXEC. EMPLOYMENT AGMT DATED AS OF 6/27/2000

 EXHIBIT 10.30.1 
  
 EXECUTIVE EMPLOYMENT AGREEMENT 
  
 This Employment Agreement (“Agreement”) is made as of June 27, 2000 by and between Exult, Inc. (the
“Company”), and Michael J. Salvino (“Executive”). 
  
 1. Duties and Responsibilities. 
  
 (a) Executive shall serve as the Company’s Executive Director, Business Development and shall report to and perform the duties and responsibilities assigned to Executive by the Company’s Vice President,
Business Development, or such other person as may be designated by the Company’s Chief Executive Officer (the “CEO”). 
  
 (b) Executive shall be based at the Company’s office located at Irvine, California. Executive will be required to attend an extensive
number of meetings at prospective clients and clients or meetings for other business purposes outside of Southern California. While not at a client site or travelling for other business purposes, Executive may work from home. 
  
 2. Period of Employment. Executive’s employment with the
Company shall be governed by this Agreement for the period commencing June 26, 2000 and continuing until this Agreement terminates pursuant to written notice by either the Company or Executive. The period during which Executive’s employment
continues in effect shall be hereafter referred to as the “Employment Period.” However, notwithstanding the foregoing, commencement of Executive’s employment will be subject to Executive’s lawful and effective cessation of any
employment or consulting relationship with any third party. 
  
 3. Cash Compensation. 
  
 (a)
Executive’s initial base salary shall be $250,000 per year payable in accordance with the Company’s standard payroll schedule. Executive’s base salary shall be subject to annual review by the Company, and may be increased or decreased
in the Company’s discretion. 
  
 (b) As part
of the sales team, Executive may be eligible for a portion of a deal pool, to be established and defined at the sole discretion of the Company, for new business booked based on Executive’s performance and contribution. Executive’s annual
sales incentive target will be $150,000, prorated for the portion of the fiscal year worked according to the Company policy. The incentive payment is intended to reward contribution to Company’s performance over an entire fiscal year, and
consequently will be paid only if Executive is employed and in good standing at the time of incentive payments, which generally occurs within 45 days after the close of the Company’s fiscal year. 
  
 (c) The Company may deduct and withhold from the
compensation payable to Executive hereunder any and all applicable federal, state and local income and employment withholding taxes and any other amounts required to be deducted or withheld by the Company under applicable statutes, regulations,
ordinances or orders, as well as any amounts that may be owed by Executive to the Company from time to time. 
  

 4. Equity Compensation. Pursuant and subject to the terms and conditions of the
Company’s 2000 Equity Incentive Plan and approval by the Company’s Board of Directors, the Company will grant to Executive an option to purchase 125,000 shares of the Company’s Common Stock. The option will vest and become exercisable
in installments over time beginning on the first anniversary of the commencement of the Employment Period and continuing for three years thereafter. The option price will be the fair market value per share of Common Stock on the date of grant.

  
 5. Expense Reimbursement. In addition to the
compensation specified in Section 3, Executive shall be entitled, in accordance with the Company’s reimbursement policies in effect from time to time, to receive reimbursement from the Company for reasonable business expenses incurred by
Executive in the performance of his duties hereunder, provided Executive furnishes the Company with vouchers, receipts and other details of such expenses in the form required by the Company sufficient to substantiate a deduction for such business
expenses under all applicable rules and regulations of federal and state taxing authorities. 
  
 6. Fringe Benefits. 
  
 (a) Executive shall, throughout the Employment Period, be eligible to participate in all executive life and disability insurance programs, group term life insurance plans, group health plans, accidental death and
dismemberment plans and disability programs and other executive perquisites that are made available to the Company’s executives and for which Executive qualifies under the Company’s policies. 
  
 (b) Executive shall earn vacation time during the Employment
Period at the rate of four (4) weeks per year. Vacation shall accrue and be taken pursuant to the Company’s vacation benefit policy set forth in the Company’s Employee Handbook. 
  
 7. Employment at Will; Severance. 
  
 (a) Executive’s employment with the Company is at will and not for a specific term and may be
terminated by either the Company or Executive at any time, for any reason without notice. Similarly, the Company may change Executive’s responsibilities, duties, title, and reporting relationships at any time for any reason. 
  
 (b) If Executive voluntarily resigns his employment without
Good Reason as defined in Section 7(c), or if the Company terminates Executive’s employment for Cause, as defined below, the Company shall have no further obligation to Executive under this Agreement or any other severance obligation
other than for accrued but unpaid salary and vacation as of the date of termination. For purposes of this Agreement, “Cause” means (i) Executive has engaged in any “Misconduct” as defined as of the date of this Agreement in the
Company’s 2000 Equity Incentive Plan; (ii) repeated failure by Executive to achieve reasonable performance standards that have been described by the Company in writing and communicated to Executive in reasonable detail, or neglect by Executive
in the performance of duties assigned to him that continues or recurs more than ten days after Executive’s receipt of written notice from the Company specifying such neglect in reasonable detail and demanding cure; or (iii) Executive’s

  

 2 

 
conviction of, or plea of nolo contendere to, any felony, or any misdemeanor involving moral turpitude or fraud. 
  
 (c) If the Company terminates Executive’s employment
other than for Cause, death or disability, or if Executive resigns his employment with Good Reason, then contingent upon execution and delivery to the Company of an unconditional release in form satisfactory to the Company of all claims against the
Company and its affiliates and the officers, directors, and employees of the Company and its affiliates, and any other persons that the Company or its affiliates would be required to indemnify, arising from or in connection with this Agreement or
Executive’s employment with the Company or the termination of that employment, Executive will be entitled to severance in an amount equal to one year’s annual salary, measured by Executive’s salary as in effect on the first day of the
fiscal year in which termination occurs, and payable in a lump sum within 90 days of termination. For these purposes, “resignation with Good Reason” means breach by the Company of this Agreement in any material respect and failure to cure
such breach within 15 days of receipt from Executive of a written demand for cure, followed by resignation by Executive of his employment within 30 days after the end of such 15-day cure period. 
  
 (d) Notwithstanding anything herein to the contrary, the
Company shall have no obligation to make any severance payments to Executive, and Executive shall return to the Company any severance payments made by the Company to Executive, if at any time before or after termination of employment Executive
breaches in any material respect any contractual or fiduciary obligation to the Company, and if such breach is susceptible of cure, fails to cure such breach within thirty days of the Company’s delivery to Executive of notice of the breach and
demand for cure, and any severance payment obligation of the Company will be suspended pending such cure. 
  
 8. Representations and Restrictive Covenants. 
  
 (a) In order to induce the Company to hire him as set forth in this Agreement, Executive represents, warrants and undertakes to the
Company as follows: 
  
 (i) Executive has been
fully advised by counsel independent of the Company of his obligations under and the terms of all agreements and other obligations applicable to his relationship with all prior employers or parties engaging Executive’s services (collectively,
the “Prior Employers”). Executive does and will rely upon his own judgment and the advice he receives from counsel independent of the Company in any action he takes (or decides not to take) in relation to all of the matters referred
to in this Agreement, but Executive will keep the Company fully informed of the nature and extent of his obligations to all Prior Employers at any time and any steps Executive proposes to take to effect his disengagement from all Prior Employers.

  
 (ii) Executive has had an opportunity to be
advised by counsel independent of the Company of his obligations under and the terms of this Agreement and the other documents referenced in Section 14. 
  

 3 

 (iii) Executive is under no contractual restriction or other restrictions or obligations
that are inconsistent with the execution of this Agreement or the performance of Executive’s duties and covenants hereunder, and will not breach any obligations to any Prior Employer. 
  
 (iv) Without in any way detracting from the generality of
paragraph (iii), Executive will not, during his employment with the Company, improperly use or disclose any confidential information, proprietary information or trade secrets belonging to any Prior Employer, or bring onto the premises of the Company
or in any other way use or refer to any unpublished document or any property belonging to any Prior Employer unless consented to in writing by such Prior Employer, and will return all property and confidential information belonging to any Prior
Employer. This is in addition to all obligations of Executive under the Confidential Information and Assignment of Inventions Agreement. 
  
 (v) Executive is under no physical or mental impairment that would interfere with Executive’s ability to perform his duties
hereunder. 
  
 (vi) Executive has full right and
power to enter into this Agreement and perform his duties and covenants hereunder without any consent from any third party. 
  
 (vii) Executive’s performance of his duties and covenants hereunder will not infringe the rights, including intellectual property
rights, of any third party. 
  
 (b) During the
Employment Period: 
  
 (i) Executive shall devote
his full business time and energy solely and exclusively to the performance of his duties to the Company, and to render his services under this Agreement fully, faithfully, diligently, and to the best of his ability. 
  
 (ii) Executive shall not directly or indirectly provide
services to or through any person, firm or other entity except the Company, unless otherwise authorized in writing by the CEO. 
  
 (iii) Executive shall not render any services of any kind or character for Executive’s own account or for any other person, firm or
entity without first obtaining the written consent of the CEO. 
  
 Executive,
however, shall have the right to perform such incidental services as are necessary in connection with (a) Executive’s private passive investments, but only if Executive is not obligated or required to (and shall not in fact) devote any
managerial efforts which interfere with the services required to be performed by him, or (b) Executive’s charitable or community activities, or participation in trade or professional organizations, but only if such incidental services do not
interfere with the performance of Executive’s services to the Company. 
  
 9. Non-Competition. During any period for which Executive is receiving wage or severance payments from the Company, Executive shall not, without prior written consent of the CEO, directly or indirectly
own, manage, operate, join, control or participate in the ownership, management, operation or control of, or be employed or engaged by or connected in any manner 

  

 4 

 
with, any enterprise that is engaged in any business competitive with the Company; provided, however, that such restriction shall not apply to any passive
investment representing an interest of less than one-half of one percent (.5%) of the publicly-traded common stock of any company or other enterprise which was not, at the time such investment was made, engaged in a business competitive with the
Company’s business. This Section 9 does not limit Executive’s obligations under the Confidential Information and Assignment of Inventions Agreement referred to in Section 11. 
  
 10. Non-Solicitation. During the Employment Period and for one (1)
year following termination of Executive’s employment, Executive shall not encourage or solicit any of the Company’s employees to leave the Company’s employ for any reason or interfere in any other manner with employment relationships
at the time existing between the Company and its employees; or solicit any client of the Company, induce any of the Company’s clients to terminate its existing business relationship with the Company or interfere in any other manner with any
existing business relationship between the Company and any client or other third party. Executive acknowledges that monetary damages may not be sufficient to compensate the Company for any economic loss that may be incurred by reason of his breach
of the foregoing restrictive covenants. Accordingly, in the event of any such breach, the Company shall, in addition to any remedies available to the Company at law, be entitled to obtain equitable relief in the form of an injunction precluding
Executive from continuing such breach. 
  
 11. Proprietary
Information and Confidentiality. 
  
 (a) As a
condition precedent to Executive’s employment with the Company, Executive will execute the Company’s standard Employee Proprietary Information and Inventions Agreement. Executive’s obligations pursuant to the Confidential Information
and Assignment of Inventions Agreement will survive termination of Executive’s employment with the Company. 
  
 (b) The Company’s business involves access to confidential and/or proprietary information about the Company’s clients and
employees of the Company’s clients (“Client Information”). Executive will comply with all policies and requirements (including without limitation execution of agreements) imposed by the Company from time to time to protect
Client Information, including in response to client requirements or applicable laws and regulations regarding protection of employee personal information. 
  
 12. Successors and Assigns. This Agreement is personal in its nature and the Executive shall not assign or transfer his rights under this
Agreement. 
  
 13. Notices. Any notices, demands or
other communications required or desired to be given by any party shall be in writing and shall be validly given to another party if served either personally or if deposited in the United States mail, certified or registered, postage prepaid, return
receipt requested. If such notice, demand or other communication shall be served personally, service shall be conclusively deemed made at the time of such personal service. If such notice, demand or other communication is given by mail, such notice
shall be conclusively deemed given forty-eight (48) hours after the deposit thereof in the United States mail addressed 

  

 5 

 
to the party to whom such notice, demand or other communication is to be given as hereinafter set forth: 
  

			
	 To the Company:
	 	Exult, Inc.
	 	 	4 Park Plaza, Suite 1000
	 	 	Irvine, California 92614
	 	 	Attention: Chief Executive Officer
		
	 With a copy to:
	 	General Counsel
		
	 To Executive:
	 	At his address of record as maintained in the Company’s employment files

  
 Any party may change its address for
the purpose of receiving notices, demands and other communications by providing written notice to the other party in the manner described in this paragraph. 
  
 14. Governing Documents. This Agreement, the Employee Proprietary Information and Inventions Agreement, and the separate documentation related to
Executive’s stock options together constitute the entire agreement and understanding of the Company and Executive with respect to the terms and conditions of Executive’s employment with the Company and the provision by the Company of any
consideration or severance benefits, and supersede all prior and contemporaneous written or verbal agreements and understandings between Executive and the Company relating to such subject matter. This Agreement may only be amended by written
instrument signed by Executive and an authorized officer of the Company. Any and all prior agreements, understandings or representations relating to the Executive’s employment with the Company are terminated and cancelled in their entirety and
are of no further force or effect. 
  
 15. Governing
Law. This Agreement will be construed and interpreted under the laws of the State of Illinois applicable to agreements executed and to be wholly performed within the State of Illinois. If any provision of this Agreement as applied to any party
or to any circumstance is adjudged by a court of competent jurisdiction to be void or unenforceable for any reason, the invalidity of that provision shall in no way affect (to the maximum extent permissible by law) the application of such provision
under circumstances different from those adjudicated by the court, the application of any other provision of this Agreement, or the enforceability or invalidity of this Agreement as a whole. If any provision of this Agreement becomes or is deemed
invalid, illegal or unenforceable in any jurisdiction by reason of the scope, extent or duration of its coverage, then such provision shall be deemed amended to the extent necessary to conform to applicable law so as to be valid and enforceable or,
if such provision cannot be so amended without materially altering the intention of the parties, then such provision will be stricken and the remainder of this Agreement shall continue in full force and effect. 
  
 16. Remedies. All rights and remedies provided pursuant to this
Agreement or by law shall be cumulative, and no such right or remedy shall be exclusive of any other. A party may pursue any one or more rights or remedies hereunder or may seek damages or specific performance in the event of another party’s
breach hereunder or may pursue any other remedy by law or equity, whether or not stated in this Agreement. 
  

 6 

 17. Arbitration. Any and all disputes between Executive and the Company that arise out of
Executive’s employment with the Company shall be resolved through final and binding arbitration. This shall include, without limitation, disputes relating to this Agreement, Executive’s employment by the Company or the termination thereof,
claims for breach of contract or breach of the covenant of good faith and fair dealing, and any claims of discrimination or other claims under Title VII of the Civil Rights Act of 1964, the Age Discrimination in Employment Act, the Americans With
Disabilities Act, the California Fair Employment and Housing Act, or any other federal, state or local law or regulation now in existence or hereinafter enacted and as amended from time to time concerning in any way the subject of Executive’s
employment with the Company or its termination. The only claims not covered by this Agreement are claims for benefits under the workers’ compensation or unemployment insurance laws, which will be resolved pursuant to those laws. Binding
arbitration will be conducted in Illinois in accordance with the rules and regulations of the American Arbitration Association. Each party will split the cost of the arbitration filing and hearing fees, and the cost of the arbitrator; each side will
bear its own attorneys’ fees, that is, the arbitrator will not have authority to award attorneys’ fees unless a statutory section at issue in the dispute authorizes the award of attorneys’ fees to the prevailing party, in which
case the arbitrator has authority to make such award as permitted by the statute in question. Executive understands and agrees that the arbitration shall be instead of any civil litigation and that this means that he is waiving his right to a jury
trial as to such claims. The parties further understand and agree that the arbitrator’s decision shall be final and binding to the fullest extent permitted by law and enforceable by any court having jurisdiction. 
  
 18. No Waiver. The waiver by either party of a breach of any provision
of this Agreement shall not operate as or be construed as a waiver of any later breach of that provision. 
  
 19. Counterparts. This Agreement may be executed in more than one counterpart, each of which shall be deemed an original, but all of which
together shall constitute but one and the same instrument. 
  

			
	Exult, Inc.
		
	By:	 	 
	 	 	

	 	 	 Kevin M. Campbell
 Operations President

	
	 
	

	 	 	Michael J. Salvino

  

 7STOCK OPTION ADDENDUM AS OF 8/25/2003 BETWEEN EXULT M.J. SALVINO

 EXHIBIT 10.30.2 
  
 STOCK OPTION ADDENDUM 
  
 This Stock Option Addendum (this “Addendum”) is entered into as of August 25, 2003 by and between Exult, Inc. (the
“Company”) and Michael J. Salvino (“Optionee”). 
  
 In consideration of Optionee’s employment with the Company and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the Company and Optionee hereby agree as follows:

  
 1. Following an Involuntary Termination that occurs at any
time within 180 days following a Change in Control, and if a Revoking Resolution has not been adopted, then subject to Section 2, all of the shares of the Company’s capital stock (or other capital stock or consideration for which Covered
Options become exercisable in connection with the Change in Control) that are at the time of the Involuntary Termination or thereafter become subject to outstanding Covered Options or issued upon exercise of Covered Options prior to vesting shall
automatically vest in full on an accelerated basis so that the Covered Options shall immediately become exercisable for all underlying shares or other consideration as fully-vested and all shares or other consideration issued upon exercise of
Covered Options prior to vesting will become free of repurchase rights. The Covered Options shall remain governed by the plan pursuant to which they were granted, including for purposes of the period for which they will remain exercisable, except to
the extent the plan is modified by a written agreement between Optionee and the Company. However, notwithstanding the foregoing, this Addendum will not extend the term or cause vesting of any Covered Options that have lapsed upon expiration of their
initial term before occurrence of the Involuntary Termination and Change in Control required to trigger vesting under this Addendum. 
  
 2. The benefits provided to Optionee under this Addendum will in each case be contingent upon and subject to Optionee’s execution and delivery to the
Company, and the effectiveness upon any applicable period of revocability, of a written release in substantially the form attached hereto as Exhibit A. 
  

3. The benefits provided to Optionee under this Addendum will be subject to appropriate income tax withholding and other deductions required by
applicable laws or regulations or approved by Optionee, and Optionee will be responsible for all income taxes (including excise taxes or surtaxes thereon) payable as a result of receipt of benefits under this Addendum. If the Company or its
successor pays any such taxes, including tax deposits, as a result of the benefits provided to Optionee under this Addendum, Optionee will upon demand promptly reimburse the Company or its successor therefor, and the Company may make exercise of
options that vest pursuant to this Addendum contingent upon arrangements to make payment and reimbursement, as appropriate, of such taxes.  
  
 4. For purposes of this Addendum, the following definitions apply: 
  
 “Cause” means (i) Optionee has engaged in any “Misconduct” as defined at the time thereof in the
Company’s 2000 Equity Incentive Plan or the successor plan thereto; or (ii) Optionee’s conviction of, or plea of nolo contendere to, any felony or misdemeanor in which the actions forming the basis for the charges for which Optionee
was convicted or to which Optionee pled nolo contendere manifested moral turpitude or fraud by Optionee, or that has a material adverse effect (including without limitation reputational effect) upon the Company, or that demonstrates that
Optionee is manifestly unfit for a position of leadership and trust in the Company. 
  
 “Change in Control” has the meaning set forth at the time thereof in the Company’s 2000 Equity Incentive Plan or the successor plan thereto, provided that for purposes hereof the threshold for a
Change 

  

 
in Control resulting from stock accumulation shall be 50% rather than 30%, and paragraph (i) of the definition of “Change in Control” in the 2000
Equity Incentive Plan shall accordingly be read to substitute 50% for 30% in each case therein. 
  
 “Covered Options” means all options to purchase capital stock of the Company or its successor issued to Optionee at any time before or
after execution of this Addendum and all options or other securities issued in replacement for such options, provided that with respect to any stock options originally issued to Optionee after the date of this Addendum (“Subsequent
Options”), the Company may specify at any time within 30 days before or after the original date of issuance thereof that such Subsequent Options are not Covered Options for purposes hereof. 
  
 “Disability” means Permanent Disability as defined at the
time thereof in the Company’s 2000 Equity Incentive Plan, or the successor plan thereto. 
  
 Resignation with “Good Reason” means (i) breach by the Company of Optionee’s Employment Agreement or any other material legal obligation to Optionee in any material respect and failure to cure
such breach within 15 days of receipt from Optionee of a written demand for cure delivered to the Company within 60 days after Optionee became aware of the breach, followed by resignation by Optionee of Optionee’s employment within 30 days
after the end of such 15-day cure period; or (ii) resignation by Optionee of Optionee’s employment within 30 days after (A) being directed to relocate Optionee’s primary work location by more than 50 miles, which relocation would increase
Optionee’s commuting distance over the distance to Optionee’s primary work location before the change, provided that if Optionee’s costs of relocation are paid outright or reimbursed under a program of forgiveness over no more than
two years following relocation, and Optionee receives such other accommodations, including income tax gross-up and any cost-of-living increases, as may be necessary so that the relocation does not result in any out-of-pocket cost to Optionee or a
material adverse effect on Optionee’s financial position or standard of living, then the relocation will not permit Optionee to resign with Good Reason; (B) Optionee’s annual salary is reduced by more than 15% from its level in
effect immediately before the effective time of the Change in Control; (C) Optionee is no longer provided with an incentive compensation program and benefits substantially comparable to the incentive compensation program and benefits in effect as of
the beginning of the year in which the Change in Control occurs; or (D) any successor to the Company or its business fails in any acquisition of the Company or its business, or any other reorganization or change-in-control transaction to assume in
full all of the obligations of the Company under this Addendum. 
  
 “Involuntary Termination” means: 
  
 (i) Optionee’s involuntary dismissal or discharge by the Company or its successor under circumstances other than Cause, death or Disability, or 
  
 (ii) Optionee’s resignation with Good Reason. 
  
 “Revoking Resolution” means a duly adopted resolution of the
Company’s board of directors, or any committee thereof, specifically declaring that this Addendum is revoked. A Revoking Resolution may only be adopted before the earlier to occur of (i) execution and delivery of a definitive binding agreement
providing for a Change in Control that is concurrently or subsequently consummated, and (ii) a duly adopted resolution of the Company’s board of directors or any committee thereof authorizing or recommending a Change in Control that is
subsequently consummated. Further, a Revoking Resolution may only be adopted (i) within 90 days following any event that would constitute Cause for termination of Optionee’s employment (even if Optionee’s employment is not terminated);
(ii) in connection with and within 90 days following a reduction in Optionee’s title, compensation, or responsibilities, provided that 

  

 2 

 
reductions in title, compensation, or responsibilities that are commensurate with similar reductions applicable to management level employees generally will
not serve as the basis for a Revoking Resolution; or (iii) within 90 days following Optionee’s failure to achieve reasonable documented performance requirements. 
  
 5. (a) Optionee acknowledges that the benefits provided by this Addendum are associated with Optionee’s position in the
Company at the time this Addendum is entered into and Optionee’s anticipated performance, and that changes in that position or performance failures or acts constituting Cause for termination of Optionee’s employment may result in
revocation of this Addendum through a Revoking Resolution. Revoking Resolutions are within the discretion of the Company’s board of directors or any committee thereof, subject to the standards set forth in the definition of “Revoking
Resolution” above, and Optionee will have no rights under this Addendum following a Revoking Resolution. 
  
 (b) Except as described in the second sentence of this Section 5(b), this Addendum supersedes any and all (i) previous agreements or
addenda related to acceleration of option vesting upon a Change in Control or “Corporate Transaction,” all of which are hereby terminated and of no further force or effect and (ii) contrary provisions of any plan pursuant to which Covered
Options are granted. However, this Addendum is a supplement to, and not a limitation of, the rights of Optionee under the plans pursuant to which the Covered Options were issued, and nothing in this Addendum limits acceleration of stock options or
other benefits provided to Optionee under stock plans of the Company or separate written agreements entered into by the Company or its successors on or after the date hereof. 
  
 (c) This Addendum will supplement but not limit any rights of Optionee to receive cash severance payments
pursuant to any separate severance plan or agreement. 
  
 (d) Without limiting the foregoing, if Optionee becomes entitled to the benefits provided under this Addendum, Section 4.14 of the Company’s 2000 Equity Incentive Plan, and any similar provisions of any other plan or agreement
otherwise applicable to Optionee or Optionee’s Covered Options, will cease to apply to, and will in no way affect or confer upon the Company, its successors, or any other party, any rights against, Optionee or Covered Options. 
  
 (e) The determination of the Company’s board of
directors or its committee, acting solely within its discretion pursuant to the standards set forth in his Addendum, regarding whether to adopt a Revoking Resolution will be determinative for purposes of this Addendum. This Addendum will not apply
to any Change in Control that is effective after the Company’s board of directors or a committee thereof adopts a Revoking Resolution. 
  
 6. The prevailing party in disputes hereunder be entitled to recover attorneys’ fees and costs. 
  
 IN WITNESS WHEREOF, the Company and Optionee have entered into this Addendum
as of the date first above set forth. 
  

									
	EXULT, INC.	 	 	 	 
					
	By:	 	 	 	 	 	 	 	 
	 	 	
	 	 	 	 	 	

	 	 	James C. Madden, V	 	 	 	 	 	Michael J. Salvino
	 	 	Chief Executive Officer	 	 	 	 	 	 

  

 3 

 Exhibit A to 
 Stock Option Addendum 
  
 Form of Release 
  
 RELEASE 
  
 THIS RELEASE (this “Release”) is entered into as of
                    , by Michael J. Salvino (“Optionee”) in consideration of and as a condition to receipt of benefits under
that certain Stock Option Addendum entered into as of August     , 2003 between Exult, Inc. and Optionee (the “Stock Option Addendum”). Optionee hereby agrees as follows: 
  
 1. Condition. Optionee acknowledges and agrees that the benefits
provided pursuant to the Stock Option Addendum are contingent upon effectiveness of this Release.  
  
 2. Release. 
  
 (a) As of the Effective Date, Optionee, for Optionee and for Optionee’s heirs, executors, administrators, successors and assigns,
does hereby fully and forever release, discharge and acquit Exult, its affiliates and their respective current and former members, partners, principals, shareholders, directors, officers, agents, attorneys, predecessors, Optionees representatives,
clients, suppliers, service providers, and contractors and the successors and assigns of each of them, (“Released Parties”), of and from any and all charges, grievances, complaints, claims, demands, obligations, promises,
agreements, damages, actions, causes of action, suits, rights, costs, losses, debts, expenses (including attorneys’ fees and costs), liabilities, and indebtedness, of every type, kind, nature, description or character, whether known or unknown,
suspected or unsuspected, liquidated or unliquidated, arising out of, relating to or in any way connected with (i) Optionee’s employment or retention with Exult or its affiliates; (ii) the termination of Optionee’s employment or retention;
(iii) any violation of local, state or federal law, including, but not limited to, the Worker Adjustment and Retraining Notification Act, Older Workers Benefit Protection Act (“OWBPA”), Americans with Disabilities Act, California
Fair Employment & Housing Act, Age Discrimination in Employment Act of 1967, as amended (“ADEA”), Title VII of the Civil Rights Act of 1964, as amended, Civil Rights Act of 1866, Rehabilitation Act of 1973, as amended, Optionee
Retirement Income Security Act of 1974, as amended, claims under the California Labor Code or other comparable state laws; (iv) wrongful termination, breach of the covenant of good faith and fair dealing, intentional or negligent infliction of
emotional distress, defamation, invasion of privacy, breach of employment contract, fraud or negligent misrepresentation; and (v) any other event, act or omission arising on or before the Effective Date (the “Released Matters”).
Notwithstanding the foregoing, the Released Matters shall not include any claims by Optionee for: (A) Optionee’s rights under the Stock Option Addendum, any other written severance agreement to which Optionee is party, any written severance
plan in which Optionee is entitled to participate, or this Release; (B) Optionee’s rights, if any, to benefits under Exult’s 401(k) plan or any other retirement plan that have accrued and vested at the time of termination of
Optionee’s employment; (C) Optionee’s rights, if any, to exercise stock options granted to Optionee that are vested but not exercised or revoked pursuant to the applicable stock option plan, and any rights under the stock option plan
pursuant to which vested options were granted; (D) statutory rights arising solely as a result of Optionee’s ownership of Exult shares and held in common with other Exult stockholders; or (E) any claim Optionee may make for unemployment or
workers’ compensation benefits.  
  
 (b) Optionee specifically agrees not to claim, and has waived any right to claim, to have been under duress in connection with the review, negotiation, execution and delivery of this Release. 
  
 (c) Optionee acknowledges and agrees that the releases made
herein constitute final and complete releases of the Released Parties with respect to all Released Matters, and that by signing this Release, Optionee is forever giving up the right to sue or attempt to recover money, damages or any other relief
from the Released Parties for all claims 

  

 4 

 
Optionee has or may have with respect to the Released Matters (even if any such claim is unforeseen as of the date hereof). 
  
 (d) Optionee represents and warrants that Optionee
understands California Civil Code Section 1542, which provides as follows: 
  
 “A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS FAVOR AT THE TIME OF EXECUTING THE RELEASE WHICH IF KNOWN BY HIM MUST HAVE MATERIALLY AFFECTED HIS
SETTLEMENT WITH THE DEBTOR.” 
  
 Optionee, being aware of Section 1542,
hereby expressly waives any and all rights Optionee may have thereunder as well as under any other statute or common law principles of similar effect under the laws of any state or the United States. This Release shall act as a release of all future
claims that may arise from the Released Matters, whether such claims are currently known or unknown, foreseen or unforeseen including, without limitation, any claims for damages incurred at any time after the date of this Release resulting from the
acts or omissions which occurred on or before the date of this Release of any of the Released Parties. 
  
 Thus, notwithstanding the provisions of Section 1542, and for the purpose of implementing a full and complete release and discharge of the Released
Parties, Optionee expressly acknowledges that this Release is intended to include in its effect, without limitation, all Released Matters which Optionee does not know or suspect to exist in his or her favor at the time of execution hereof, and that
this Release contemplates the extinguishment of all such Released Matters. 
  
 3. No Claims. Optionee represents and warrants that Optionee has not instituted any complaints, charges, lawsuits or other proceedings against any Released Parties with any governmental agency, court,
arbitration agency or tribunal. Optionee further agrees that, except to the extent that applicable law prohibits such agreements, Optionee will not, directly or indirectly, (i) file, bring, cause to be brought, join or participate in, or provide any
assistance in connection with any complaint, charge, lawsuit or other proceeding or action against any Released Parties at any time hereafter for any Released Matters, (ii) assist, encourage, or support Optionees or former Optionees or stockholders
or former stockholders of Exult or any of its affiliates in connection with any lawsuit, charge, claim or action they may initiate, unless compelled to testify by appropriate civil processes; or (iii) defend any action, proceeding or suit in whole
or in part on the grounds that any or all of the terms or provisions of this Release are illegal, invalid, not binding, unenforceable or against public policy. In addition, Optionee will refrain from bringing or dismiss, as applicable, any claim
against any third party if any Released Party would be required to defend or indemnify that third party in connection with such claim. If any agency or court assumes jurisdiction of any complaint, charge, or lawsuit against Exult or any Released
Party, on Optionee’s behalf, Optionee agrees to immediately notify such agency or court, in writing, of the existence of this Release, including providing a copy of it and to request, in writing, that such agency or court dismiss the matter
with prejudice. 
  
 4. Advice of Counsel. Optionee
represents and agrees that he or she fully understands his or her right to discuss, and that Exult has advised Optionee to discuss, all aspects of this Release with Optionee’s private attorney, that Optionee has carefully read and fully
understands all the provisions of the Release, that Optionee understands its final and binding effect, that Optionee is competent to sign this Release and that Optionee is voluntarily entering into this Release. 
  
 5. Acknowledgment. Optionee represents and agrees that in executing
this Release Optionee relies solely upon his or her own judgment, belief and knowledge, and the advice and recommendations of any independently selected counsel, concerning the nature, extent and duration of Optionee’s rights and claims.
Optionee acknowledges that no other individual has made any promise, representation or warranty, express or 

  

 5 

 
implied, not contained in this Release, to induce Optionee to execute this Release. Optionee further acknowledges that Optionee is not executing this Release
in reliance on any promise, representation, or warranty not contained in this Release. 
  
 6. Return of Property. Optionee will immediately return all Exult property, documents, files, records, equipment, instruction manuals and other items concerning the business of Exult, its parent or subsidiary
companies, or any related entity that are in Optionee’s possession or under Optionee’s control. 
  
 7. Non-Disclosure. Optionee further agrees to keep the terms of this Release confidential, and that, with the exception of his or her spouse and
legal counsel or as compelled by law, Optionee will not disclose any information concerning this Release to anyone. 
  
 8. Binding on Successors and Assigns. This Release shall inure to the benefit of and be binding upon the successors and assigns of Exult and
shall inure to the benefit of and be binding upon Optionee’s heirs, executors, administrators, successors and assigns. 
  
 9. Arbitration. Optionee acknowledges and agrees that any dispute regarding the application, interpretation or breach of this Release will be
subject to final and binding arbitration before the American Arbitration Association (“AAA”) (an entity unaffiliated with Exult which provides arbitration services), which will be the exclusive remedy for such claim or dispute. Such
claim or dispute shall be resolved by one (1) arbitrator that shall be mutually selected by Optionee and Exult. If Optionee and Exult cannot mutually select an arbitrator, the arbitrator shall be appointed in accordance with the then-existing
commercial arbitration rules of the AAA. Any resolution, opinion or order of the AAA may be entered as a judgment in any court of competent jurisdiction. This Release shall be admissible in any proceeding to enforce its terms.  
  
 10. Severability. If any provision of this Release is found, held,
declared, determined, or deemed by any court of competent jurisdiction to be void, illegal, invalid or unenforceable under any applicable statute or controlling law, the legality, validity, and enforceability of the remaining provisions will not be
affected and the illegal, invalid, or unenforceable provision will be deemed not to be a part of this Release  
  
 11. Governing Law. This Release shall be construed and interpreted in accordance with California law.  
  
 12. Confidential Information and Inventions Agreement. Optionee hereby
reaffirms all of Optionee’s agreements and covenants set forth in that certain Confidential Information and Inventions Agreement by and between Optionee and Exult or the Proprietary Information and Inventions Agreement, as applicable.

  
 13. Entire Agreement. This Release contains the entire
agreement and understanding between Optionee and Exult regarding the matters set forth herein and replaces all prior agreements, arrangements and understandings, written or oral regarding the subject matter hereof, but releases given for
consideration other than benefits under the Stock Option Addendum will not be affected by this Release. This Release cannot be amended, modified, supplemented, or altered, except by written amendment or supplement signed by Optionee and Exult.
 
  
 14. Counterparts. This Release may be executed
in counterparts, each of which shall be deemed an original, but all of which shall constitute but one and the same instrument. Facsimile transmission of this Release and/or retransmission of any signed facsimile transmission will be deemed the same
as delivery of an original and will be binding for all purposes. 
  
 15. Review and Effectiveness. 
  
 (a) This Section 16(a) applies only to Optionees aged under forty (40). This Release is effective as of the date first written above (the “Effective Date”). 
  
 (b) This Section 16(b) applies only to Optionees aged
forty (40) and above. 
  

 6 

 (i) Optionee acknowledges that prior to signing this Release, Optionee was offered up to
forty-five (45) days to consider whether to sign this Release. Optionee further acknowledges receiving the disclosures required under the ADEA and OWBPA attached hereto. 
  
 (ii) Optionee understands that he or she is entitled to revoke this Release within seven (7) days after its
execution. The eighth (8th) day after Optionee’s execution and delivery of this Release will be the
“Effective Date”. This Release will be effective and enforceable beginning on the Effective Date unless Optionee delivers written revocation of this Release to Exult’s General Counsel at 121 Innovation Drive, Suite 200, Irvine,
California 92612, facsimile / (949) 856-8802 before the Effective Date, in which case this Release will be of no force or effect; and 
  
 (iii) Optionee acknowledges that Section 4 regarding Optionee’s consultation with his or her attorney applies, among other
things to the ADEA and OWBPA. 
  
 IN WITNESS WHEREOF, Optionee has
executed this Release as of the date first written above. 
  

	
	OPTIONEE
	
	 
	

	Michael J. Salvino

  

 7

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00061-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00061-of-00352.parquet"}]]